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We assessed the presence, frequency and pattern of MRI abnormalities in non-dystrophic myotonia patients. We reviewed
T1-weighted and STIR (short-tau-inversion-recovery) 3T MRI sequences of lower limb muscles at thigh and calf level in 21 patients
with genetically conﬁrmed non-dystrophic myotonia: 11 with CLCN1 mutations and 10 with SCN4A mutations, and 19 healthy
volunteers. The MRI examinations of all patients showed hyperintensity within muscles on either T1-weighted or STIR images. Mild
extensive or marked T1-weighted changes were noted in 10/21 patients and no volunteers. Muscles in the thigh were equally likely to
be aﬀected but in the calf there was sparing of tibialis posterior. Oedema was common in calf musculature especially in the medial
gastrocnemius with STIR hyperintensity observed in 18/21 patients. In 10/11 CLCN1 patients this included a previously unreported
“central stripe”, also present in 3/10 SCN4A patients but no volunteers. Degree of fatty inﬁltration correlated with age (rho = 0.46,
p < 0.05). Muscle MRI is frequently abnormal in non-dystrophic myotonia providing evidence of fatty inﬁltration and/or oedema.
The pattern is distinct from other myotonic disorders; in particular the “central stripe” has not been reported in other conditions.
Correlations with clinical parameters suggest a potential role for MRI as a biomarker.
 2013 The Authors. Published by Elsevier B.V. All rights reserved.
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In many neuromuscular disorders MRI plays an
important role in diagnosis and an increasing role in
disease monitoring [1,2]. However there is little published
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muscle channelopathy and are classiﬁed as myotonia
congenita (MC), paramyotonia congenita (PMC) or
sodium channel myotonia (SCM) according to their
clinical features [3]. Both dominant and recessive forms
of myotonia congenita are caused by mutations in the
CLCN1 gene [4] whilst both PMC and SCM are caused
by mutations in the SCN4A gene [5]. Each subgroup of
NDM has a distinct clinical phenotype but there can be
overlap between the groups and also with myotonic
dystrophy type 2. Advanced electrophysiological
techniques aid genetic testing [6], but a signiﬁcant
minority may need analysis of several candidate genes
before a diagnosis is reached.. All rights reserved.
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of many neuromuscular disorders [1,2]. Typical
ﬁndings are areas of hyperintensity within muscles on
T1-weighted (T1w) images due to fatty inﬁltration [7].
The pattern of fatty inﬁltration can help determine the
defective gene responsible [8], particularly in congenital
myopathies [1]. Hyperintensity on fat-suppressed T2-weighted
sequences such as short-tau-inversion-recovery (STIR)
represent muscle oedema which may be due to toxic,
metabolic or inﬂammatory changes [9]. In skeletal muscle
channelopathies published MRI research is more limited.
Whilst signiﬁcant T1 and STIR abnormalities have been
reported in hypokalemic periodic paralysis [10], few [11]
or no [12] abnormalities have been reported in NDM
using T1w or STIR MRI sequences.
The objective of this study was to deﬁne the frequency
and nature of any abnormalities on lower limb MRI in
patients with genetically proven NDM compared with
healthy volunteers.
2. Materials and methods
2.1. Subjects
In a 12 month period between June 2009 and June 2010
we identiﬁed 21 patients (12 males and 9 females, mean
age 45.6 years, standard deviation 14.4 years, range
19–68 years) with genetically conﬁrmed non-dystrophic
myotonia seen at our service in whom MRI had been
undertaken using the imaging protocol detailed below.
The local ethics committee conﬁrmed that the project
conformed to research governance arrangements. The
NDM patients included the following subtypes: dominant
MC (n = 3), recessive MC (n = 8), PMC (n = 3) and
SCM (n = 7). Clinical data was collated including age of
onset, clinical phenotype, genetic mutation and use of
medication (Table 1).
For comparison, we reviewed scans of 19 healthy
volunteers with similar age range to the patients (12
female, 7 male, mean age 32 years, range 21–55 years) who
had been imaged using the same sequences as part of a
parallel research study with approval of the local ethics
committee.
2.2. MRI protocol
All subjects were scanned at 3T (Siemens TIM Trio,
Erlangen, Germany) in a supine position with surface array
coils to receive the signal from the thighs and calves of both
limbs. Patients were scanned with a clinical imaging
protocol comprising T1w axial imaging (representative
parameters: repetition time (TR)/echo time (TE) = 575/
19 ms, number of signal averages (NEX) = 1, 384  228
matrix) and axial STIR imaging (representative parameters
TR/TE/inversion time (TI) = 4900/47/220 ms, 2 signal
averages, 320  192 matrix) with 5 mm slice thickness and
1 mm slice gap. Sequence parameters varied betweenindividuals to ensure full anatomical coverage and to meet
speciﬁc absorption rate restrictions, with scanning time
being usually less than 20 min. Healthy volunteer images
were drawn from an existing study dataset with T1w: TR/
TE = 671/16 ms, NEX = 1 and STIR: TR/TE/TI = 5500/
56/220 ms, NEX = 1, both with 10 mm slice thickness,
10 mm slice gap and a 256  192matrix.
2.3. MRI analysis
We ﬁrst analyzed individual muscles and subsequently
categorized the overall degree of involvement at thigh and
calf level. The following individual muscles were assessed
bilaterally: rectus femoris, vastus intermedius, vastus
lateralis, vastus medialis, semimembranosus,
semitendinosus, biceps femoris, adductor magnus, gracilis
and sartorius in the thigh; tibialis anterior, peroneus
longus, medial gastrocnemius, lateral gastrocnemius,
soleus and tibialis posterior in the calf. These 32 muscles
were assessed on T1w sequences for the presence of
fatty inﬁltration using Fischer’s semi-quantitative scale [8]:
0 – normal appearance, 1 – occasional scattered T1
hyperintensity, 2 – conﬂuent areas of T1 hyperintensity
<50% of muscle involved, 3 – conﬂuent areas of T1
hyperintensity >50%, 4 – complete replacement of muscle
with fat. The same muscles were assessed on the STIR
sequences for presence of hyperintensity indicative of
oedema and were graded on a three point scale: 0 – absent,
1 – mild or 2 – deﬁnite hyperintensity. Patient MRI scans
were independently analysed by two neuroradiologists with
post-specialist experience in neuromuscular imaging (three
years: author AF, one year: IA in acknowledgements) who
were blinded to clinical details. There was exact agreement
in Fischer grading for 81% of muscles, whilst 17% of
muscles diﬀered by a single grade. All disagreements in
ratings were resolved in a consensus meeting of these two
radiologists together with a senior neuroradiologist with
over 20 years post-speciality experience (author TY). In a
separate session a single neuroradiologist (AF) analyzed
the scans from the 19 healthy volunteers using the same
methods.
Taking into account the volunteer data, we created an
overall categorization for each sequence. The T1
weighted sequences (thighs or calves) were categorized as:
 Normal: all muscles grade 0.
 Mild limited changes: grade 1 changes in 650% of the
muscles (610/20 in thighs; 66/12 in calves).
 Mild extensive changes: grade 1 changes in >50% of the
muscles.
 Marked changes: any muscle with grade 2 changes.
The STIR sequences were similarly categorized:
 Normal: all muscles normal intensity.
 Mild limited changes: mild hyperintensity in 61/3 of the
muscles (66/20 in thighs; 64/12 in calves).
Table 1
Clinical characteristics of patients and MRI ﬁndings.
ID Age Sex Channel Mutation Phenotype Medication Thigh Calf Overall
score
T1 STIR T1 STIR Stripe
1 40 M CLCN1 Gly285Glu Dominant
MC
Nil    + Yes 0
2 51 F CLCN1 Ala313Val Dominant
MC
Disopyramide   ++ ++ Yes 0.13
3 63 M CLCN1 Gly230Glu Dominant
MC
Mexiletine    ++ Yes 0
4 19 M CLCN1 c.[1261C>T (+)
2596–11C>G];
p.[Arg421Cys (+) ?]
Recessive
MC
Mexiletine   ± ± Yes 0.04
5 20 F CLCN1 c.[180+3A>T (+)
1251+4A>C]; p.[? (+) ?]
Recessive
MC
Nil     Yes 0
6 29 M CLCN1 p.[Gly222Ser;
Arg976X]+[Pro558Ser]
Recessive
MC
Mexiletine     Yes 0
7 40 M CLCN1 c.[696+2_696+
10del(+)1183_1187del];
p.[?(+)Gly395fs]
Recessive
MC
Mexiletine +  ± ++ No 0.63
8 40 M CLCN1 c.1167–10T>C &
deletion of exons 8–10
Recessive
MC
Mexiletine    ++ Yes 0
9 50 M CLCN1 c.[180+3A>T
(+) 568G>A];
p. [? (+) Gly190Arg]
Recessive
MC
Mexiletine +  ±  Yes 0.40
10 51 M CLCN1 p.[Val327Ile (+)
Arg894X]
Recessive
MC
Quinine ++  ± ± Yes 0.65
11 54 F CLCN1 c.[180+3A>T (+)
568G>A]; p. [? (+)
Gly190Arg]
Recessive
MC
Mexiletine +  + ± Yes 0.71
12 42 F SCN4A Thr1313Met PMC Nil   ± ± Yes 0.04
13 58 F SCN4A Arg1448Leu PMC Phenytoin ++  ++ + No 0.65
14 68 M SCN4A Thr1313Met PMC Mexiletine   ++ ++ No 0.25
15 25 F SCN4A Gly1306Ala SCM Mexiletine    ± No 0
16 37 F SCN4A Gly1306Ala SCM Nil    ± Yes 0
17 43 M SCN4A Leu1436Pro SCM Nil ++  ++  No 2.43
18 47 M SCN4A Val1589Met SCM Nil ±  ± ± Yes 0.17
19 57 F SCN4A Val1589Met SCM Nil   + ++ No 0.21
20 57 F SCN4A Leu128Pro SCM Mexiletine ++ – + ± No 0.80
21 68 M SCN4A Gly1306Ala SCM Mexiletine   ±  No 0.04
M: male, F: female, CLCN1: voltage-sensitive chloride channel gene, SCN4A: voltage-gated sodium channel gene, MC: myotonia congenita, PMC:
paramyotonia congenita, SCM: sodium channel myotonia, STIR: short-tau-inversion-recovery. : all muscle normal, ±: mild limited changes, +: mild
extensive changes, ++: marked changes (as deﬁned in the methods). Overall score: mean T1 grade across all muscles.
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the muscles.
 Marked changes: any muscle with marked
hyperintensity.
2.4. Statistical considerations
For the purposes of pattern analysis left and right values
for each patient were averaged and only descriptive
statistics were used. An overall MRI involvement score
was established for each patient by calculating the mean
of the qualitative scores of all 32 muscles. Spearman’s
rank correlation coeﬃcient was used to assess correlation
between overall MRI involvement score and age.
Statistical analyses were performed using PASW Statistics
18, Release Version 18.0.0 (= D3 SPSS, Inc., 2009,
Chicago, IL, www.spss.com).
3. Results
The MRI examinations of all 21 patients showed
hyperintensity within muscles on either T1w or STIRimages. The categorization of T1w and STIR, thigh and
calf images is detailed in Table 1 (patients) and Table 2
(volunteers) and is summarized by group in Table 3.
Representative images from patients and volunteers are
shown in Fig. 1. Further images are available in online
Supplementary material, Fig. e1.3.1. T1w abnormalities
All scans were adequate in quality and coverage to allow
assessment of all deﬁned muscles in all subjects, Fatty
inﬁltration was found in 30% (128/420) of thigh muscles
and in 37% (94/252) of calf muscles in patients, and in
8% (32/380) of thigh muscles and 9% (21/228) of calf
muscles in volunteers. In volunteers all changes were
Fischer grade 1. In patients, the fatty inﬁltration covered
all grades: thigh: grade 1: 101 muscles (between 7
patients), grade 2: 9 muscles (4 patients), grade 3: 8
muscles (1 patient), grade 4: 10 muscles (1 patient); calf:
grade 1: 78 muscles (14 patients), grade 2: 7 muscles (4
patients), grade 3: 5 muscles (1 patient), grade 4: 4
muscles (1 patient). All grade 3 and 4 muscles were from
a single patient (patient 17 in Table 1, see also Fig. 1B).
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appear to be diﬀerences between clinical subgroups in
distribution of muscles involved within the calf or thigh.
There was not a speciﬁc pattern of muscle involvement in
the thigh (Fig. 2A left), although one patient had
markedly diﬀerent degrees of involvement between
muscles (Fig. 1B). In the calf however, there was relative
sparing of fatty changes in tibialis posterior (2/21)
(Fig. 2A right).
Overall fatty changes in patients were categorized as
mild extensive in 14% (3/21) and marked in 19% (4/21),
for both calf and thigh sequences (Tables 1 and 3). While
a proportion of both patient and control T1w thigh or
calf images were categorized as having mild limited
changes, no volunteer scans were assigned to higher
categories (Tables 2 and 3).
3.2. STIR abnormalities
STIR hyperintensity, reﬂecting oedema, was not
identiﬁed in any of the thigh images, but was identiﬁed in
the calf images in 90% (19/21) of patients. Mild STIR
hyperintensity in calf muscles was found in 53% (10/19)
of healthy volunteers but was usually limited to the
gastrocnemius muscles and was categorized as mild
limited changes in eight of the volunteers.
The STIR hyperintensity in patients was more
commonly categorized as mild extensive or marked
than in volunteers (8/21 vs 2/19). In patients STIR
hyperintensity was most common in the medial
gastrocnemius muscle (15/21), followed by the lateral
gastrocnemius muscle (9/21 patients) and tibialis
anterior muscle (5/21 patients) (Fig. 2A). The STIR
hyperintensity in calf muscles seen in patients was more
widespread and of greater intensity than in healthy
volunteers (Fig. 2B).
During the analysis, we noticed the presence of a
hyperintense stripe in the medial gastrocnemius in a
number of patients (Fig. 1C). We therefore assessed the
frequency of this ﬁnding in a separate session. The
presence of his feature was deﬁned as a hyperintenseTable 2
Summary of MRI ﬁndings on thigh and calf imaging in healthy volunteers.
Number of volunteers Thigh C
T1 STIR T
8   
1   
2   ±
2 ±  
1  ± 
2 ±  ±
1 ± ± ±
1  ± 
1 ±  ±
The volunteers are grouped according to scan ﬁndings.  = all muscle norm
changes (as deﬁned in the methods). Overall score: mean T1 grade across allstripe identiﬁable on more than one slice, parallel to the
external circumference of the muscle and extending more
than one third of the muscle on an axial image. The
central stripe was present in 14/21 patients (10/11
CLCN1, 3/10 SCNA4). The central stripe was not
present on any of the scans of the 19 healthy volunteers.
The central stripe was present in 75% (6/8) of patients
whose scans otherwise showed only mild limited changes
(Table 1).3.3. Clinical MRI correlations
The correlation between overall MRI involvement and
age was signiﬁcant (rho = 0.46, p < 0.05) despite the
diversity in phenotype and genotype. The correlation was
stronger (rho = 0.76, p < 0.05) for the largest subgroup,
recessive MC (Fig. 3). The average number of muscles
with oedema was similar in patients on treatment (n = 14,
3.4) and patients not on treatment (n = 7, 3.3).3.4. Overall spectrum of imaging ﬁndings
There was a wide spectrum of ﬁndings when all images
were considered together for each patient (Table 1,
Fig. 1). A total of 10/21 patients had at least mild
extensive T1w changes compared with no volunteers. One
patient showed severe fatty replacement of some muscles
and marked variation between muscles but no STIR
hyperintensity. Five further patients had marked T1w
changes (Fischer grade 2) in some muscles with
additional STIR abnormality in four of these. A further
4 patients had mild extensive T1w changes in muscles of
the thigh, calf or both with additional STIR
abnormalities in all.
Of the 11 patients without deﬁnite T1w changes, 9 had
the central stripe either with (3 patients) or without (6
patients) additional mild extensive STIR hyperintensity in
the calf. This leaves just two patients who had only mild
limited abnormalities and lay within the spectrum of
healthy volunteer ﬁndings.alf Overall score
1 STIR Stripe
 No 0
± No 0
± No 0.08
± No 0.08
± No 0
± No 0.34
 No 0.47
++ No 0
+ No 0.19
al, ± = mild limited changes, + = mild extensive changes, ++ = marked
muscles.
Table 3
Overall categorization of T1w and STIR sequences in patients and controls.
Sequence No abnormalities Mild limited Mild extensive Marked
T1 weighted sequences
Thigh patient 62% (13/21) 5% (1/21) 14% (3/21) 19% (4/21)
Thigh control 68% (13/19) 32% (6/19) 0 0
Calf patient 33% (7/21) 33% (7/21) 14% (3/21) 19% (4/21)
Calf control 68% (13/19) 32% (6/19) 0 0
STIR sequences
Thigh patient 100% (21/21) 0 0 0
Thigh control 84% (16/19) 16% (3/19) 0 0
Calf patient 24% (5/21) 38% (8/21) 10% (2/21) 29% (6/21)
Calf control 47% (9/19) 42% (8/19) 5% (1/19) 5% (1/19)
See methods for category deﬁnitions.
Fig. 1. (A) Range of appearances in healthy volunteers. Left (T1w right calf): normal appearance of all muscles; middle (T1w right calf): mild streaks of
hyperintensity in some muscles, right: (STIR left calf) mild STIR hyperintensity in lateral gastrocnemius (arrowhead), marked STIR hyperintensity in
peroneus longus (arrow). (B) 43 year old man with SCM (patient 17). Top (T1w right thigh): severe fatty changes with almost complete replacement of the
hamstrings by fat, with relative sparing of the adductor longus and gracilis (asterisks); bottom (T1w right calf): complete fatty replacement of the posterior
superﬁcial compartment with sparing of tibialis anterior and tibialis posterior (arrowheads). (C) 40 year old man with dominant MC (patient 1), STIR
both calves. The “central stripe” in both left and right medial gastrocnemius muscles (arrowheads) and mild hyperintensity in both lateral gastrocnemius
muscles. (D) 58 year old woman with PMC (Patient 13). Left (T1w right calf) Marked T1 changes with conﬂuence of T1 hyperintensity evident in medial
gastrocnemius (arrow); right (STIR right calf): STIR hyperintensity in many calf muscles (arrowheads).
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We have described the spectrum of MRI abnormalities
in genetically conﬁrmed non-dystrophic myotonia. Weidentiﬁed signal abnormalities in all patients. Almost half
(10/21) of the patients had at least mild extensive T1w
changes which were not found in any healthy volunteers.
Furthermore a “central stripe” of STIR hyperintensity
Fig. 2. Distribution of fatty inﬁltration and oedematous changes across thigh and calf muscles. (A) Patients, (B) healthy volunteers.
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volunteers. Only two patients had changes categorized as
no more than mild limited.
Very few studies have examined MRI changes in NDM.
One study [11] assessed sodium MRI spectroscopy in
patients with SCN4A gene mutations. The imaging
protocol included T1w, T2w and STIR sequences. They
reported T2w abnormalities in one of sixteen NDM
patients overall although T2w abnormalities were more
common following cooling in the PMC group. The T1wand STIR results were not speciﬁcally reported. A further
study [12] reported no abnormalities in three patients
with recessive myotonia congenita using whole body
MRI including T1w, T2w and fat-suppressed T2w
sequences. Diﬀerences in age could be a contributing
factor to this discrepancy. In our study there were less
T1w changes in young compared to older recessive MC
were less in young patients than older patients (see
Fig. 3, ﬁlled circles). Subtle abnormalities such as the
central stripe of STIR hyperintensity may be more
Fig. 3. Correlation between age and fatty inﬁltration on MRI. Scatter-plot of age versus fat score in all 21 patients. (A) signiﬁcant correlation (rho = 0.46,
p < 0.05) is observed, which is stronger in the largest subgroup, the recessive myotonia congenita group (rho = 0.76, p < 0.05, trend line shown). Marked
points refer to sample images in Fig. e1. MC: myotonia congenita, PMC: paramyotonia congenital, SCM: sodium channel myotonia.
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limb rather than whole body protocols [12].
Although collectively termed “non-dystrophic”
myotonias to diﬀerentiate them from myotonic
dystrophy, the ﬁnding of abnormalities on MRI in
patients with myotonia congenita, sodium channel
myotonia and paramyotonia congenita is not unexpected.
Imaging abnormalities are in keeping with the clinical
observation that a proportion of these patients develop
ﬁxed weakness and muscle biopsy ﬁndings in these
patients may show myopathic changes, tubular
aggregates and vacuolar changes [3]. Our results are
consistent with an ultrasound study of NDM patients
which showed increased echogenicity suggestive of fatty
inﬁltration or ﬁbrosis of left biceps brachii, right forearm
ﬂexors and left tibialis anterior compared with healthy
volunteers [13]. However, ultrasound examination is
limited to superﬁcial muscle groups and is operator
dependent with relatively low inter-observer and intra-
observer agreement [9].
4.1. T1w MRI pattern
Although the degree of fatty inﬁltration was mild
overall, the group was heterogeneous ranging fromnormal T1w scans (7/21 patients) to a patient with severe
changes (Table 1). No speciﬁc pattern within thigh or calf
muscles distinguished clinical subgroups of patients. The
diﬀuse pattern of fatty inﬁltration noted in this study is
diﬀerent from that reported in patients with myotonic
dystrophy where more selective involvement of muscles is
seen especially in myotonic dystrophy type 1 [14]. This
may help diﬀerentiate NDM from other myotonic
disorders.
The degree of abnormality on T1w MRI is greater than
that seen in healthy volunteers in whom T1 signal
hyperintensity was noted in 9% of individual muscles in
this study. Overall 8/19 volunteers were categorized as
having mild limited T1w changes at thigh or calf level.
That scattered area of T1 hyperintensity within muscle
may be seen in healthy adult volunteers is an important
observation of this study. A recent publication included
semi-quantitative assessment using a scale broadly similar
to the Fischer scale of T1w calf MRI in children with
Duchenne muscular dystrophy and healthy children. The
mean grade assigned to diﬀerent calf muscles in healthy
children ranged between 0.5 and 1.1 [15]. The mean grade
in our adult healthy volunteers at calf level ranged
between 0 and 0.2. Although the mean age and gender
distribution diﬀered slightly between the patient group
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average Fischer grading increased with age in the healthy
volunteers (rho = 0.12, p = 0.63), nor any gender
diﬀerence (p = 0.65). There were also minor diﬀerences in
acquisition parameters such as slice thickness in some
subjects, however these are unlikely to have a signiﬁcant
eﬀect on qualitative Fischer grading.
This study stresses the importance of assessing the
spectrum of MRI appearances in volunteers, to allow
better categorisation of the relevance of mild changes in
patients. In this study the cut-oﬀ of any muscle with
conﬂuent T1w hyperintensity (Fischer grade 2) or more
than half muscles with streaks of hyperintensity (Fischer
grade 1) was eﬀective in separating the patient and
volunteer groups and might be used as a benchmark for
future studies. However, if the detection of mild
abnormalities in a group of patients is required, a
suitably matched control group should be considered as
these abnormalities may vary depending on age or gender.
4.2. STIR MRI pattern
STIR hyperintense changes were muscle speciﬁc. No
STIR hyperintensity was detected in the thigh muscles of
any of the patients. However, STIR abnormalities (the
central stripe, mild extensive or marked hyperintensity)
were detected in the calves of 90% of patients and 10% of
volunteers. The most commonly involved muscle was the
medial gastrocnemius followed by the lateral
gastrocnemius and the tibialis anterior muscles. The
pattern of hyperintensity within the muscle was striking
with a central stripe of STIR hyperintensity in the medial
gastrocnemius of 10 out of 11 patients with myotonia
congenita and 3 out of 10 patients with PMC/SCM. We
did not see a similar pattern in our healthy volunteers
and to our knowledge, it has not been reported to date in
any other diseases. The central stripe could be an MRI
sign suggestive of non-dystrophic myotonia, especially
myotonia congenita and could therefore be an additional
aid to guiding genetic testing.
The speciﬁc localization of the STIR hyperintensity as a
central stripe within the medial gastrocnemius is of interest.
Anatomically the central stripe corresponds to the motor
endplate zone of medial gastrocnemius due to the pinnate
arrangement of muscle ﬁbers which pass from superﬁcial
to deep as they run from proximal to distal [16].
Furthermore animal studies have shown greatest
concentration of CLCN1 channels at the neuromuscular
junction [17], which may explain the increased
susceptibility of this region to pathological changes in
patients with myotonia congenita.
Hyperintensity on STIR imaging is commonly referred
to as “muscle oedema”; although the exact correlate of
this term at the tissue level is poorly understood. At a
basic level STIR hyperintensity results from prolongation
of T2 relaxation times due to changes in tissue water
distribution. Increased T2 times have been documented inhealthy muscle after exercise due to a number of
proposed mechanisms including water shift from intra- to
extra-cellular spaces, increase in extra-cellular or vascular
ﬂuid volumes, and increase in proportion of “free” water
to macromolecular “bound” water [18]. Considering that
myotonia represents abnormally prolonged muscle
contraction, similar mechanisms may be the cause of
STIR hyperintensity in NDM. Further insight is gained
from a sodium spectroscopy MRI study which included
patients with SCM and PMC. They found reduced
intracellular sodium concentration at baseline which
increased following cold provocation. All PMC patients
also developed STIR hyperintensity after provocation
postulated to be due to the accumulation of water within
muscle ﬁbers driven by the increased intracellular sodium
concentration [11].
We detected evidence of abnormal muscle water
distribution in 90% of NDM patients without speciﬁc
provocation and only a small minority (2/19) of healthy
volunteers using the cut-oﬀ for abnormal of >1/3 of
muscles mildly hyperintense, or at least one muscle with
marked STIR hyperintensity, or the central stripe of
hyperintensity within the medial gastrocnemius muscle.
This cut-oﬀ deﬁnition was useful to divide the mild STIR
hyperintensity seen in a small number of muscles in some
volunteers from abnormal STIR hyperintensity within the
patient group.
This STIR hyperintensity in volunteers has not to our
knowledge been previously reported, though qualitative
analysis of skeletal muscle MRI in healthy volunteers is
rare [15]. The hyperintensity was mild in degree and
generally in just the distal portion of medial or lateral
gastrocnemius. The typical appearance is depicted in
lateral gastrocnemius bilaterally in Supplemental Fig. 1C.
This was overall seen in 8/19 volunteers in medial
gastrocnemius and 5/19 volunteers in lateral
gastrocnemius, and did not appear to be due to ﬁeld
inhomogeneity or inadequate fat suppression.
Quantitative studies have reported longer T2 in medial
gastrocnemius than tibialis anterior in healthy volunteers
[19,20] or the variation may represent diﬀerences in
recent exercise which can also aﬀect muscle T2 [21] but
wasn’t speciﬁcally controlled for in this qualitative study.
The STIR ﬁndings again highlight the importance of
comparison with healthy volunteers to prevent
misclassiﬁcation of mild hyperintensity in some muscles
as abnormal. Future studies could investigate this in
greater detail by using a more sophisticated scale to
describe STIR changes, such as that proposed by
Poliachik [22] or by applying quantitative methods to
measure muscle T2.
4.3. Clinical implications
There was correlation between age and overall MRI
score in the overall patient group. This correlation was
even stronger in the recessive MC subgroup suggesting
J.M. Morrow et al. / Neuromuscular Disorders 23 (2013) 637–646 645that T1w MRI changes progress with age however a
longitudinal study would be needed to conﬁrm this.
Longitudinal imaging would also answer important
questions regarding the temporal relationship between
oedema and fatty inﬁltration. Although no correlation
was seen between medication use and number of muscles
with STIR hyperintensity, this might be explained by the
worse aﬀected patients being more likely to be on
medications. Whether sequences sensitive to changes in
water distribution might be able to detect a treatment
aﬀect will need to be assessed in an interventional or
longitudinal study.
The fatty inﬁltration of muscles seen in this series clearly
indicates that progressive irreversible muscle damage does
occur in some patients with non-dystrophic myotonia. It
is unknown if any of the current therapies used in NDM
have any inﬂuence on the development of myopathy and
it is not known whether medication can reverse the MRI
abnormalities in this group of patients, although such a
reversal has been demonstrated in hypokalaemic periodic
paralysis [10]. By combining methods to quantify
abnormal water distribution [10] with muscle fat
measurements [23], MRI may also be useful as an
outcome measure in future treatment trials of non-
dystrophic myotonia.
In conclusion, lower limb muscle MRI in patients with
non-dystrophic myotonia revealed fatty inﬁltration and
oedema in the majority of patients. Although T1w
changes in most patients were mild overall, hyperintensity
was present to a greater degree than in controls and
some patients demonstrated extensive fatty inﬁltration.
STIR changes were also more common and furthermore,
we described a previously unreported STIR hyperintense
central stripe within the medial gastrocnemius muscle,
which we identiﬁed consistently especially in patients with
myotonia congenita and could be of diagnostic use.
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